BPC-157, short for Body Protection Compound-157, is a synthetic peptide derived from a naturally occurring protein found in the stomach
Our finding that several diseases show lowered blood NAD + levels and overall imbalanced redox metabolites is intriguing, as it suggests that a variety of disease processes increase NAD + usage, potentially by activated repair processes including PARP enzymes a major user of NAD +8 .The results have high potential relevance for clinical and research applications, follow-up of metabolic interventions and detection of disease-induced NAD + or glutathione deficiency to select patients for treatment
That means the combined pharmacology, the potential for compounded side effects, and any interaction with the drugs used around surgery are essentially uncharacterized
In order to do this, certain genes that previously were silent, or down-expressed, have to be activated, while others have to be silenced